-+ 0.00%
-+ 0.00%
-+ 0.00%

CLARITY PHARMACEUTICALS - MOST ADVERSE EVENTS AT 8 GBQ DOSE WERE MILD OR MODERATE AND TRANSIENT

Reuters·08/05/2026 13:05:12

Please log in to view news